Get started
Author

Kimia Z. Assadi

Observed names: KIMIA ASSADI, Kimia Assadi
ORCID: 0009-0002-3354-2984
Observed ORCID: 0009-0002-3354-2984
OpenAlex ID: A5096677252
Glycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report
2024 · Halis K. Akturk, Kagan E. Karakus, et al. · Journal of Diabetes Science and Technology · 6
PDF
The 3Cs Framework for Pain and Unhealthy Substance Use: Minimum Core Competencies for Interprofessional Education and Practice
2022 · Eric Holmboe, Steve Singer, et al. · NAM Perspectives · 4
Real‐world outcomes using the Tandem Mobi insulin pump with Control‐ IQ + technology and Dexcom G7
2026 · Edwin W. D'Souza, Jessica R. Castle, et al. · Diabetic Medicine
First Use of Control-IQ+ Technology in Newly Indicated Populations
2026 · Kimia Z. Assadi, Edwin W. D’Souza, et al. · Diabetes Technology & Therapeutics
1869-P: High User Satisfaction Continues over Time with Tandem Mobile Apps and Control-IQ+ Technology
2026 · KIMIA ASSADI, EDWIN W. D'SOUZA, et al. · Diabetes
Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States
2026 · Neda Al Rawashdh, Bimal V. Patel, et al. · Diabetes Obesity and Metabolism
Author response for "Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients with Type 2 Diabetes in the United States"
2026 · Neda Al Rawashdh, Bimal V. Patel, et al.
958-P: High User Satisfaction and Ease-of-Use Scores with Six Months Use of the Tandem t:connect Mobile Application
2024 · KIMIA ASSADI, MICHELLE L. MANNING, et al. · Diabetes
Works count: 8
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type